Takeover

TNGXTango Therapeutics, Inc.

Pharmaceutical Preparations

Revenue
$62MFY2021: $37MFY2022: $25MFY2023: $37MFY2024: $42MFY2025: $62M
48% YoY
Operating margin
-178.4%FY2021: -157.1%FY2022: -446.8%FY2023: -312.6%FY2024: -346.1%FY2025: -178.4%
48% YoY
EBITDA
−$109MFY2021: −$57MFY2022: −$109MFY2023: −$112MFY2024: −$143MFY2025: −$109M
24% YoY
Market cap
$3.8B
Employees
137
$455K revenue each
Net debt / EBITDA
—
AI in 10-K
3.6
mentions per 10K words

Takeover score 3 of 13

Fixable underperformance 2 of 7

Buyer economics 1 of 4

Catalysts 0 of 2

Financials

MetricFY2021FY2022FY2023FY2024FY2025YoYTrend
Revenue$37M$25M$37M$42M$62M 48% FY2021: $37MFY2022: $25MFY2023: $37MFY2024: $42MFY2025: $62M
Operating income−$58M−$111M−$114M−$146M−$111M 24% FY2021: −$58MFY2022: −$111MFY2023: −$114MFY2024: −$146MFY2025: −$111M
Net income−$58M−$108M−$102M−$130M−$102M 22% FY2021: −$58MFY2022: −$108MFY2023: −$102MFY2024: −$130MFY2025: −$102M
Operating cash flow−$60M−$109M−$118M−$132M−$139M 5.6% FY2021: −$60MFY2022: −$109MFY2023: −$118MFY2024: −$132MFY2025: −$139M
Capex$2M$8M$2M$754K$1M 39% FY2021: $2MFY2022: $8MFY2023: $2MFY2024: $754KFY2025: $1M
Stock-based comp$8M$14M$19M$29M$26M 8.5% FY2021: $8MFY2022: $14MFY2023: $19MFY2024: $29MFY2025: $26M

Deal filings

None.

13D filers

FiledFilerFormStakeIntent
Feb 10, 2026Third Rock Ventures IV, L.P.SCHEDULE 13D/A4.7%Passive
Nov 21, 2025Third Rock Ventures IV, L.P.SCHEDULE 13D/A5.8%Passive
Nov 14, 2025Third Rock Ventures IV, L.P.SCHEDULE 13D/A7.0%Passive
Jan 2, 2025BCTG Holdings, LLCSCHEDULE 13D/A10.0%Passive
Nov 7, 2024Boxer Capital Management, LLCSC 13D/A6.5%Passive
Oct 28, 2024Boxer Capital Management, LLCSC 13D/A6.5%Passive
Oct 15, 2024Boxer Asset Management Inc.SC 13D/A0.0%Passive
Oct 15, 2024Boxer Capital, LLCSC 13D/A14.3%Passive
Sep 4, 2024Third Rock Ventures IV, L.P.SC 13D/A15.9%Passive
Oct 18, 2023BCTG Holdings, LLCSC 13D/A6.9%Passive

Insider trading

Open-market buys, 12 mo
$0 · 0
Open-market sells, 12 mo
$8M · 25
Net
−$8M

Pay vs performance

YearCEO total compComp actually paidTSR (indexed)Peer TSR
FY2025$3M$10M——
FY2024$7M−$3M——
FY2023$3M$8M——